Drugs / BI 3731579
Trials 3 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06861829 | Mar → Apr 2025 | — | Boehringer Ingelheim | Completed | No outcome recorded |
| Phase 1 | NCT06716190 | Dec 2024 → May 2025 | — | Boehringer Ingelheim | Terminated | No outcome recorded |
| Phase 1 | NCT06429137 | Jul 2024 → May 2025 | — | Boehringer Ingelheim | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BI 3731579 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06716190 ↗ |